Literature DB >> 23129080

15-year follow-up of recurrent "hypoglycemia" in preterm infants.

Win Tin1, Greta Brunskill, Tom Kelly, Susan Fritz.   

Abstract

BACKGROUND: Observational study of 543 infants who weighed <1850 g, published in 1988 reported seriously impaired motor and cognitive development at 18 months in those with recurrent, asymptomatic hypoglycemia (plasma glucose level ≤2.5 mmol/L on ≥3 days). No study has yet replicated this observation. AIM: To quantify disability in a similar cohort of children followed up throughout childhood. POPULATION: All children born at <32 weeks' gestation in the north of England in 1990-1991 and had laboratory blood glucose levels measured daily for the first 10 days of life.
RESULTS: Forty-seven index children of the 566 who survived to 2 years had a blood glucose level of ≤2.5 mmol/L on ≥3 days. All of these children and hypoglycemia-free controls, matched for hospital of care, gestation, and birth weight, were assessed at age 2. No differences in developmental progress or physical disability were detected. The families were seen again when the children were 15 years old, and 38 of the index children (81%) and matched controls agreed to detailed psychometric assessment. Findings in the 2 groups were nearly identical (mean full-scale IQ: 80.7 vs 81.2). Findings in the 21 children with a level of ≤2.5 mmol/L on ≥4 days, 7 children with a level this low on 5 days, and 11 children with a level of <2.0 mmol/L on 3 different days did not alter these conclusions.
CONCLUSIONS: This study found no evidence to support the belief that recurrent low blood glucose levels (≤2.5 mmol/L) in the first 10 days of life usually pose a hazard to preterm infants.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23129080     DOI: 10.1542/peds.2012-0776

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  23 in total

Review 1.  Neonatal hypoglycemia: is 60 the new 40? The questions remain the same.

Authors:  D H Adamkin; R Polin
Journal:  J Perinatol       Date:  2016-01       Impact factor: 2.521

2.  50 years ago in the Journal of pediatrics: The incidence of neonatal hypoglycemia in a nursery for premature infants.

Authors:  Satya Houin; Paul Joseph Rozance
Journal:  J Pediatr       Date:  2014-06       Impact factor: 4.406

Review 3.  Hypoglycemia in the preterm neonate: etiopathogenesis, diagnosis, management and long-term outcomes.

Authors:  Anudeepa Sharma; Ajuah Davis; Prem S Shekhawat
Journal:  Transl Pediatr       Date:  2017-10

4.  What's new in glucose control in the ICU?

Authors:  Greet Van den Berghe
Journal:  Intensive Care Med       Date:  2013-03-05       Impact factor: 17.440

5.  Modern Management of Preterm Infants Prevents Adverse Developmental Outcomes From Hypoglycemia.

Authors:  Paul J Rozance; William W Hay
Journal:  Pediatrics       Date:  2016-11-04       Impact factor: 7.124

Review 6.  An emerging evidence base for the management of neonatal hypoglycaemia.

Authors:  Jane E Harding; Deborah L Harris; Joanne E Hegarty; Jane M Alsweiler; Christopher Jd McKinlay
Journal:  Early Hum Dev       Date:  2016-12-15       Impact factor: 2.079

7.  A Quality-Improvement Initiative to Reduce NICU Transfers for Neonates at Risk for Hypoglycemia.

Authors:  Sherry LeBlanc; Jamie Haushalter; Carl Seashore; Karen S Wood; Michael J Steiner; Ashley G Sutton
Journal:  Pediatrics       Date:  2018-02-08       Impact factor: 7.124

8.  Beyond Anesthesia Toxicity: Anesthetic Considerations to Lessen the Risk of Neonatal Neurological Injury.

Authors:  Mary Ellen McCann; Jennifer K Lee; Terrie Inder
Journal:  Anesth Analg       Date:  2019-11       Impact factor: 5.108

9.  Developmental Outcomes of Preterm Infants With Neonatal Hypoglycemia.

Authors:  Rachel H Goode; Mallikarjuna Rettiganti; Jingyun Li; Robert E Lyle; Leanne Whiteside-Mansell; Kathleen W Barrett; Patrick H Casey
Journal:  Pediatrics       Date:  2016-11-04       Impact factor: 7.124

Review 10.  Update on neonatal hypoglycemia.

Authors:  Paul J Rozance
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2014-02       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.